Gary J. Kelloff
Impact in
- Biochemistry top 0.2%
- Phytochemicals and Antioxidant Activities
- Antioxidant Activity and Oxidative Stress
- Cancer Research top 0.5%
- Cancer, Lipids, and Metabolism
Papers in
-
- Genomics, phytochemicals, and oxidative stress 30
- Retinoids in leukemia and cellular processes 24
- Genetics 82
- Estrogen and related hormone effects 38
- Virus-based gene therapy research 28
- Co-authors
- Vernon E. Steele (82 shared papers)Caroline C. Sigman (51 shared papers)Ronald A. Lubet (64 shared papers)Charles W. Boone (37 shared papers)Chinthalapally V. Rao (11 shared papers)James A. Crowell (38 shared papers)Ernest T. Hawk (22 shared papers)R Lubet (11 shared papers)
- Journals
- Journal of Cellular Biochemistry (32 papers)Carcinogenesis (15 papers)JNCI Journal of the National Cancer Institute (9 papers)Clinical Cancer Research (9 papers)Virology (6 papers)
- Partner nations
- United StatesCanadaMalaysia
In The Last Decade
Gary J. Kelloff
268 papers receiving 14.0k citations
Gary J. Kelloff's Hit Papers
Peers
Comparison fields: 5 of 170
- Biochemistry 1.2k
- Cancer Research 2.2k
- Molecular Medicine 743
- Pharmacology 2.0k
- Toxicology 397
Countries citing papers authored by Gary J. Kelloff
This map shows the geographic impact of Gary J. Kelloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary J. Kelloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary J. Kelloff more than expected).
Fields of papers citing papers by Gary J. Kelloff
This network shows the impact of papers produced by Gary J. Kelloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary J. Kelloff. The network helps show where Gary J. Kelloff may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary J. Kelloff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 273 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Hit paper breakdown → | 1999 | 511 |
| 2 | Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development Hit paper breakdown → | 2005 | 502 |
| 3 | 2008 | 395 | |
| 4 | 2000 | 382 | |
| 5 | Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review. | 1990 | 347 |
| 6 | Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia Hit paper breakdown → | 2017 | 344 |
| 7 | 1999 | 340 | |
| 8 | Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. | 1997 | 263 |
| 9 | Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. | 1996 | 261 |
| 10 | 1999 | 259 | |
| 11 | Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. | 1994 | 227 |
| 12 | 2000 | 220 | |
| 13 | Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. | 2000 | 218 |
| 14 | 2000 | 212 | |
| 15 | Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. | 1995 | 210 |
| 16 | 1996 | 207 | |
| 17 | Chemoprevention of colon carcinogenesis by organosulfur compounds. | 1993 | 204 |
| 18 | Lipoxygenase inhibitors as potential cancer chemopreventives. | 1999 | 202 |
| 19 | 2000 | 200 | |
| 20 | Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. | 1990 | 196 |
About Gary J. Kelloff
Gary J. Kelloff is a scholar working on Molecular Biology, Genetics, Cancer Research, Oncology and Pharmacology, having authored 273 papers that have together received 14.6k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (38 papers), Inflammatory mediators and NSAID effects (31 papers), Genomics, phytochemicals, and oxidative stress (30 papers), Virus-based gene therapy research (28 papers), Retinoids in leukemia and cellular processes (24 papers), Cancer, Lipids, and Metabolism (20 papers), Cancer Genomics and Diagnostics (19 papers) and Animal Virus Infections Studies (18 papers). The work is most often cited by research in Biochemistry (1.2k citations), Cancer Research (2.2k citations), Molecular Medicine (743 citations), Pharmacology (2.0k citations) and Toxicology (397 citations). Gary J. Kelloff has collaborated with scholars based in United States, Canada and Malaysia. Frequent co-authors include Vernon E. Steele, Caroline C. Sigman, Ronald A. Lubet, Charles W. Boone, Chinthalapally V. Rao, James A. Crowell, Ernest T. Hawk, R Lubet, Clinton J. Grubbs and Vernon E. Steele. Their work appears in journals such as Journal of Cellular Biochemistry, Carcinogenesis, JNCI Journal of the National Cancer Institute, Clinical Cancer Research and Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.